LWLiang Wang

Liang Wang

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Liang Wang has a total of 14 co-authors. Here are the top co-authors by number of shared publications:

  • Chenlu Ge

    Prenatal Diagnosis Center, the Second Hospital of Hebei Medical University, Shijiazhuang

    1 shared publication
  • Ci Liu

    Prenatal Diagnosis Center, the Second Hospital of Hebei Medical University, Shijiazhuang

    1 shared publication
  • Hu Liu

    Department of Neurology, The Second Hospital of Hebei Medical University, Shijiazhuang, China

    1 shared publication
  • Jie Li

    Department of Emergency, Harrison International Peace Hospital Affiliated to Hebei Medical University, Hengshui

    1 shared publication
  • Jiyuan Zhang

    Department of Neurology, The Second Hospital of Hebei Medical University, Shijiazhuang, China

    1 shared publication
  • Mei Tian

    Department of Neurology, The Second Hospital of Hebei Medical University, Shijiazhuang, China

    1 shared publication

Latest Publications

  • Open Access

    Case Report: Recurrent pathogenic mutation c.110G>A in DHDDS gene

    by Ci Liu, Qiaoyu Ye, Jie Li, Siming Bu, Chenlu Ge, Xiangnan Wang, Moyuan Quan, Liang Wang

    Recent studies have demonstrated the close association of mutations in the dehydrodolichyl diphosphate synthase ( DHDDS) gene with neurodevelopmental disorders and the onset of epilepsy. This report describes a female patient harboring a de novo heterozygous variant c.110G>A (p.Arg37His) in the DHDDS gene, characterized by childhood-onset myoclonus-like movement disorder (at age 6) and late-onset epilepsy (at age 17). The movement disorder was remarkably improved through the levetiracetam+ clonazepam+ haloperidol triple therapy, and epileptic seizures were also effectively controlled. A retrospective analysis of 59 epilepsy patients with DHDDS gene variants revealed significant clinical heterogeneity in disease phenotypes caused by DHDDS mutations. Epilepsy was identified as the predominant symptom, commonly accompanied by movement disorders and varying degrees of intellectual disability. Furthermore, while pathogenic mutations in DHDDS tend to be relatively clustered, no definitive genotype-phenotype correlation has been established. This study highlights the clinical manifestations, imaging features, treatment experiences, and genetic testing results through case reports and literature review, thereby providing crucial references for the clinical diagnosis, treatment, and further research of such diseases.

  • Open Access

    Identification of key genes and diagnostic model associated with circadian rhythms and Parkinson’s disease by bioinformatics analysis

    by Jiyuan Zhang, Xiaopeng Ma, Zhiguang Li, Hu Liu, Mei Tian, Ya Wen, Shan Wang, Liang Wang

    Background: Circadian rhythm disruption is typical in Parkinson’s disease (PD) early stage, and it plays an important role in the prognosis of the treatment effect in the advanced stage of PD. There is growing evidence that circadian rhythm genes can influence development of PD. Therefore, this study explored specific regulatory mechanism of circadian genes (C-genes) in PD through bioinformatic approaches.Methods: Differentially expressed genes (DEGs) between PD and control samples were identified from GSE22491 using differential expression analysis. The key model showing the highest correlation with PD was derived through WGCNA analysis. Then, DEGs, 1,288 C-genes and genes in key module were overlapped for yielding differentially expressed C-genes (DECGs), and they were analyzed for LASSO and SVM-RFE for yielding critical genes. Meanwhile, from GSE22491 and GSE100054, receiver operating characteristic (ROC) was implemented on critical genes to identify biomarkers, and Gene Set Enrichment Analysis (GSEA) was applied for the purpose of exploring pathways involved in biomarkers. Eventually, immune infiltrative analysis was applied for understanding effect of biomarkers on immune microenvironment, and therapeutic drugs which could affect biomarkers expressions were also predicted. Finally, we verified the expression of the genes by q-PCR.Results: Totally 634 DEGs were yielded between PD and control samples, and MEgreen module had the highest correlation with PD, thus it was defined as key model. Four critical genes (AK3, RTN3, CYP4F2, and LEPR) were identified after performing LASSO and SVM-RFE on 18 DECGs. Through ROC analysis, AK3, RTN3, and LEPR were identified as biomarkers due to their excellent ability to distinguish PD from control samples. Besides, biomarkers were associated with Parkinson’s disease and other functional pathways.Conclusion: Through bioinformatic analysis, the circadian rhythm related biomarkers were identified (AK3, RTN3 and LEPR) in PD, contributing to studies related to PD treatment.